Nov 27, 2024
How Antibiotic Underuse Is Driving Antimicrobial Resistance;
What to Know About the XEC SARS-CoV-2 Variant
Related Content:
Nov 22, 2024
A recent Special Communication published in JAMA points out that
the FDA has already approved nearly 1000 devices using AI. Author
Robert M. Califf, MD, commissioner of the US Food and Drug
Administration, joins JAMA+ AI Editor in Chief Roy H. Perlis, MD,
MSc, to discuss AI regulation.
Related Content:
Nov 15, 2024
A recent JAMA Cardiology essay argues that medicine is not just a technical endeavor, it's also a moral endeavor, and a robot does not have moral agency. Coauthor Sarah C. Hull, MD, MBE, of Yale School of Medicine, joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss the use of AI in...
Nov 8, 2024
Widespread adoption of AI raises questions about accountability,
transparency, and reproducibility. Marcia McNutt, PhD, president of
the National Academy of Sciences, joins JAMA Editor in Chief
Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss advancing
scientific knowledge in the age of AI.
Related Content: